Emerald Mutual Fund Advisers Trust Travere Therapeutics, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.77 Billion
- Q3 2024
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 1,185,709 shares of TVTX stock, worth $21.8 Million. This represents 0.94% of its overall portfolio holdings.
Number of Shares
1,185,709
Previous 941,265
25.97%
Holding current value
$21.8 Million
Previous $7.74 Million
114.4%
% of portfolio
0.94%
Previous 0.44%
Shares
5 transactions
Others Institutions Holding TVTX
# of Institutions
193Shares Held
83.6MCall Options Held
776KPut Options Held
900K-
Armistice Capital, LLC New York, NY7.65MShares$140 Million1.78% of portfolio
-
Black Rock Inc. New York, NY7.64MShares$140 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.9MShares$127 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD4.68MShares$86.1 Million2.23% of portfolio
-
Woodline Partners LP San Francisco, CA4.34MShares$79.7 Million0.55% of portfolio
About Travere Therapeutics, Inc.
- Ticker TVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,173,600
- Market Cap $1.18B
- Description
- Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...